Phosphoric Acid

Phosphoric Acid

SCHEMBL8529442

Nc1ccc([N+](=O)[O-])cn1.O=P(O)(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.50
ADRA2B P18089 2/20 0.50
ADRA2C P18825 2/20 0.50
SLC2A1 P11166 1/20 0.46
MAPT P10636 5/20 0.46
LMNA P02545 3/20 0.46
GAA P10253 2/20 0.45
CYP1A2 P05177 1/20 0.45
ALDH1A1 P00352 3/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX12 P18054 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL9079479 0.93 ADRA2A (0.47) ADRA2AADRA2BADRA2CSLC2A1MAPT
SCHEMBL116229 0.91 MAPT (0.53) ADRA2AADRA2BADRA2CSLC2A1MAPT
SCHEMBL3024397 0.91 MAPT (0.53) ADRA2AADRA2BADRA2CSLC2A1MAPT
Methane SCHEMBL28159882 0.89 MAPT (0.52) ADRA2AADRA2BADRA2CSLC2A1MAPT
Hydrochloric Acid SCHEMBL8872527 0.89 ADRA2A (0.54) ADRA2AADRA2BADRA2CSLC2A1MAPT
Acetone SCHEMBL28243789 0.86 CYP1A2 (0.57) ADRA2AADRA2BADRA2CSLC2A1MAPT
Cadaverine Tartrate SCHEMBL28586029 0.80 ADRA2A (0.45) ADRA2AADRA2BADRA2CSLC2A1MAPT
Cadaverine Tartrate SCHEMBL28598769 0.80 ADRA2A (0.45) ADRA2AADRA2BADRA2CSLC2A1MAPT
Carbromal SCHEMBL9170995 0.78 CYP2C19 (0.42) ADRA2AADRA2BADRA2CMAPTLMNA
SCHEMBL19461607 0.76 MAPT (0.71) MAPTLMNAGAACYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0570250-B1 Crystalline structure of monohydrogentartrates, process for its preparation and application thereof FRANCE TELECOM (FR) 1998-06-03 EP disclosed
EP-0619308-B1 Crystalline structures of halides of 2-amino-5-nitro-pyridinium, process for their preparation and an electrooptical device with such structures FRANCE TELECOM (FR) 1998-03-11 EP disclosed
US-5637717-A 2-amino-5-nitropyridinium halide crystal structure and process for the preparation of said crystal structures FRANCE TELECOM (FR) 1997-06-10 US disclosed
US-5374734-A Monohydrogentartrate crystalline structure having nonlinear quadratic effects FRANCE TELECOM (FR) 1994-12-20 US disclosed
EP-0619308-A1 Crystalline structures of the hydrogen chloride salt of 2-amino-5-nitro-pyridinium, process for their preparation and an electrooptical device with such structures FRANCE TELECOM (FR) 1994-10-12 EP disclosed
EP-0570250-A2 Crystalline structure of monohydrogentartrates, process for its preparation and application thereof FRANCE TELECOM (FR) 1993-11-18 EP disclosed
EP-0488869-A1 Salts of 2-amino-5-nitropyridinium for non-linear and electro-optic use, and a process for their preparation FRANCE TELECOM (FR) 1992-06-03 EP disclosed